![Rodger Novak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rodger Novak
Gründer bei
Xap Therapeutics Ltd
Profil
Rodger Novak gründete die CRISPR Therapeutics AG und die Nabriva Therapeutics GmbH. Derzeit ist Dr. Novak Chairman & President der CRISPR Therapeutics AG. In der Vergangenheit war er Global Head-Anti Infectives Research & Development bei Sanofi Pharma SA, Chief Operating Officer für Nabriva Therapeutics GmbH, Head-Scientific & Medical Affairs am Antibiotic Research Institute, Deputy Head-Antibiotic Research Institute bei Sandoz AG, Deputy Head-Antibiotic Research Institute bei Sandoz GmbH und Professor-Mikrobiologie am Vienna Biocenter. Rodger Novak hat an der Philipps-Universität Marburg promoviert.
Aktive Positionen von Rodger Novak
| Unternehmen | Position | Beginn |
|---|---|---|
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01.10.2020 |
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Direktor/Vorstandsmitglied | 01.01.2014 |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Direktor/Vorstandsmitglied | - |
Xap Therapeutics Ltd
 Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Gründer | - |
Ehemalige bekannte Positionen von Rodger Novak
| Unternehmen | Position | Ende |
|---|---|---|
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01.01.2025 |
| CRISPR THERAPEUTICS AG | Vorstandsvorsitzender | 01.12.2017 |
Sanofi AG | Corporate Officer/Principal | 01.11.2013 |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | 01.12.2005 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Gründer | - |
Ausbildung von Rodger Novak
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Antibiotic Research Institute
 Antibiotic Research Institute Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research | Commercial Services |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz GmbH
 Sandoz GmbH Pharmaceuticals: MajorHealth Technology Manufactures generic pharmaceuticals and biotechnological drugs | Health Technology |
Sanofi AG | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Vienna Biocenter
 Vienna Biocenter Miscellaneous Commercial ServicesCommercial Services Operates biology research center | Commercial Services |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Xap Therapeutics Ltd
Xap Therapeutics Ltd Pharmaceuticals: MajorHealth Technology Develops multi-modal therapies to treat complex diseases: cancer and autoimmunity | Health Technology |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Commercial Services |
